LRRC15 and cancer: In line with the frequent LRRC15 expression in SCC cancer-associated fibroblasts (81% of cases) [101], an anti-LRRC15 MMAE-conjugated ADC, ABBV-085, triggered complete response in SCC xenograft (PDX) models [101].